Citations de notices

Style de citation APA (7e éd.)
Pape, K., Rolfes, L., Steffen, F., Muthuraman, M., Korsen, M., Meuth, S. G., . . . Bittner, S. (2022). Comparative effectiveness of natalizumab ocrelizumab in multiple sclerosis: A real-world propensity score–matched study. SAGE Publishing.
Style de citation Chicago (17e éd.)
Pape, Katrin, Leoni Rolfes, Falk Steffen, Muthuraman Muthuraman, Melanie Korsen, Sven G. Meuth, Frauke Zipp, et Stefan Bittner. Comparative Effectiveness of Natalizumab Ocrelizumab in Multiple Sclerosis: A Real-world Propensity Score–matched Study. SAGE Publishing, 2022.
Style de citation MLA (9e éd.)
Pape, Katrin, et al. Comparative Effectiveness of Natalizumab Ocrelizumab in Multiple Sclerosis: A Real-world Propensity Score–matched Study. SAGE Publishing, 2022.
Attention : ces citations peuvent ne pas être correctes à 100%.